BD Picks Up Retractable Syringe Technology Through Med-Design Deal
This article was originally published in The Gray Sheet
Executive Summary
BD Corp. will broaden its protective sharps technology portfolio and enter the retractable sharps market in May with the introduction of Med-Design's Safety Auto-Retract Intravenous Catheter, executives from Med-Design explained during an April 5 teleconference.
You may also be interested in...
End-Users Should Have Greater Input In Sharps Safety Purchasing - Panel
Rapid advances in sharps safety technology are making it more imperative that frontline health care workers have more input in facility decisions to purchase the devices, panelists at the Premier Sharps Safety Forum agreed April 5 in Crystal City, Virginia.
California Court’s Inaction On TiO2 Prop 65 First Amendment Case Breeds New Lawsuits
The Personal Care Products Council seeks to stem the rising tide of titanium dioxide Proposition 65 lawsuits, requesting that a California court prohibit the state’s Attorney General and private enforcers from filing and/or prosecuting new suits against cosmetics companies failing to warn about potential TiO2 exposure.
Kenvue Breaks Ground On New Headquarters, Appoints Chief Corporate Affairs Officer
Firm hosts groundbreaking for 290,000 square-foot global headquarters it’s having built in Summit, NJ, starting with 100,000 square-foot science and innovation and expected to open in 2025. It announced adding Russell Dyer as chief corporate affairs officer starting 13 March.